2-tert-butylhydroquinone has been researched along with oxidopamine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adachi, T; Hara, H; Kuno, S; Ohta, K; Ohta, M | 1 |
Jakel, RJ; Johnson, DA; Johnson, JA; Kern, JT | 1 |
Cao, TT; Hess, JF; Kandpal, G; Ma, L; Seabrook, GR; Warren, L | 1 |
Jakel, RJ; Johnson, JA; Kraft, AD; Townsend, JA | 1 |
Li, HY; Shi, N; Wu, SY; Zhong, YF | 1 |
Chandrasekaran, K; Desai, V; Fiskum, G; Jafri, MS; Siebert, A | 1 |
6 other study(ies) available for 2-tert-butylhydroquinone and oxidopamine
Article | Year |
---|---|
Increase of antioxidative potential by tert-butylhydroquinone protects against cell death associated with 6-hydroxydopamine-induced oxidative stress in neuroblastoma SH-SY5Y cells.
Topics: Antioxidants; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; Glutathione; Humans; Hydroquinones; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Models, Neurological; NAD(P)H Dehydrogenase (Quinone); Neuroblastoma; Neurons; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; Reactive Oxygen Species; RNA, Messenger; Transcriptional Activation | 2003 |
Induction of the protective antioxidant response element pathway by 6-hydroxydopamine in vivo and in vitro.
Topics: Animals; Antioxidants; Apoptosis; Astrocytes; Brain Stem; Corpus Striatum; DNA-Binding Proteins; Female; Hydroquinones; Mice; NF-E2-Related Factor 2; Oxidative Stress; Oxidopamine; Parkinson Disease; Receptors, N-Methyl-D-Aspartate; Response Elements; Trans-Activators | 2005 |
Increased nuclear factor-erythroid 2 p45-related factor 2 activity protects SH-SY5Y cells against oxidative damage.
Topics: 1-Methyl-4-phenylpyridinium; Blotting, Western; Cell Survival; DNA-Binding Proteins; Genes, Reporter; Humans; Hydroquinones; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Luciferases; Molsidomine; NF-E2-Related Factor 2; Oxidative Stress; Oxidopamine; Plasmids; Proteins; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Signal Transduction; Trans-Activators | 2005 |
Nrf2-mediated protection against 6-hydroxydopamine.
Topics: Animals; Astrocytes; Cell Death; Cell Transplantation; Cells, Cultured; Cerebral Cortex; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Embryo, Mammalian; Female; Green Fluorescent Proteins; Hydroquinones; In Situ Nick-End Labeling; Mice; Mice, Knockout; Neurons; Neurotoxins; NF-E2 Transcription Factor, p45 Subunit; Oxidopamine; Transfection; Tyrosine 3-Monooxygenase | 2007 |
NF-E2 related factor 2 activation and heme oxygenase-1 induction by tert-butylhydroquinone protect against deltamethrin-mediated oxidative stress in PC12 cells.
Topics: Animals; Antioxidants; Calcium; Heme Oxygenase-1; Hydroquinones; Immunohistochemistry; Insecticides; NF-E2-Related Factor 2; Nitriles; Oxidation-Reduction; Oxidative Stress; Oxidopamine; PC12 Cells; Pyrethrins; Rats; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation | 2007 |
Nrf2 activators provide neuroprotection against 6-hydroxydopamine toxicity in rat organotypic nigrostriatal cocultures.
Topics: Animals; Antioxidants; Cell Death; Coculture Techniques; Corpus Striatum; Cytoprotection; Dopamine; Gene Expression; Hydroquinones; Isothiocyanates; NAD(P)H Dehydrogenase (Quinone); Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidopamine; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sulfoxides; Thiocyanates | 2009 |